BR0109293A - Métodos para produzir polissacarìdeo capsular a partir de um pneumococo pela manutenção do pneumococo em um meio de crescimento, para minorar uma infecção pneumocócica em um animal, para produzir uma preparação imunogênica para a administração a um animal em risco de desenvolver uma infecção pneumocócica, para produzir polissacarìdeo pneumocócico e para avaliar se um composto de teste é útil para minorar uma infecção pneumocócica em um animal - Google Patents

Métodos para produzir polissacarìdeo capsular a partir de um pneumococo pela manutenção do pneumococo em um meio de crescimento, para minorar uma infecção pneumocócica em um animal, para produzir uma preparação imunogênica para a administração a um animal em risco de desenvolver uma infecção pneumocócica, para produzir polissacarìdeo pneumocócico e para avaliar se um composto de teste é útil para minorar uma infecção pneumocócica em um animal

Info

Publication number
BR0109293A
BR0109293A BR0109293-6A BR0109293A BR0109293A BR 0109293 A BR0109293 A BR 0109293A BR 0109293 A BR0109293 A BR 0109293A BR 0109293 A BR0109293 A BR 0109293A
Authority
BR
Brazil
Prior art keywords
animal
pneumococcal
pneumococcus
pneumococcal infection
produce
Prior art date
Application number
BR0109293-6A
Other languages
English (en)
Other versions
BRPI0109293B1 (pt
BRPI0109293B8 (pt
Inventor
Jeffrey N Weiser
Original Assignee
Philadelphia Children Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22699002&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0109293(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Philadelphia Children Hospital filed Critical Philadelphia Children Hospital
Publication of BR0109293A publication Critical patent/BR0109293A/pt
Publication of BRPI0109293B1 publication Critical patent/BRPI0109293B1/pt
Publication of BRPI0109293B8 publication Critical patent/BRPI0109293B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

"MéTODOS PARA PRODUZIR POLISSACARìDEO CAPSULAR A PARTIR DE UM PNEUMOCOCO PELA MANUTENçãO DO PNEUMOCOCO EM UM MEIO DE CRESCIMENTO, PARA MINORAR UMA INFECçãO PNEUMOCóCICA EM UM ANIMAL, PARA PRODUZIR UMA PREPARAçãO IMUNOGêNICA PARA A ADMINISTRAçãO A UM ANIMAL EM RISCO DE DESENVOLVER UMA INFECçãO PNEUMOCóCICA, PARA PRODUZIR POLISSACARìDEO PNEUMOCóCICO E PARA AVALIAR SE UM COMPOSTO DE TESTE é úTIL PARA MINORAR UMA INFECçãO PNEUMOCóCICA EM UM ANIMAL " A invenção refere-se a métodos de modulação da produção de polissacarídeo capsular em pneumococos, tais que Streptococcus pneumoniae. A invenção refere-se ainda a métodos para minorar infecções pneumocócicas em animais, e a métodos de identificação de ambos os agentes capazes de modular infecções pneumocócicas em animais. A figura (1), que compreende as figuras 1Ai-Avi e 1Bi-1Bvi constitui uma série de imagens, que indicam o efeito da concentração de dióxido de carbono e oxigênio ambiental sobre a morfologia da colónia e o tamanho da cápsula, conforme avaliado usando a reação de Quellung.
BRPI0109293A 2000-03-16 2001-03-16 métodos para produzir polissacarídeo capsular a partir de um pneumococo, para produzir uma preparação imunogênica para a administração a um animal em risco de desenvolver uma infecção pneumocócica, e para produzir polissacarídeo pneumocócico BRPI0109293B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18984700P 2000-03-16 2000-03-16
PCT/US2001/008442 WO2001068903A1 (en) 2000-03-16 2001-03-16 Modulating production of pneumococcal capsular polysaccharide

Publications (3)

Publication Number Publication Date
BR0109293A true BR0109293A (pt) 2003-06-10
BRPI0109293B1 BRPI0109293B1 (pt) 2015-05-19
BRPI0109293B8 BRPI0109293B8 (pt) 2021-05-25

Family

ID=22699002

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0109293A BRPI0109293B8 (pt) 2000-03-16 2001-03-16 métodos para produzir polissacarídeo capsular a partir de um pneumococo, para produzir uma preparação imunogênica para a administração a um animal em risco de desenvolver uma infecção pneumocócica, e para produzir polissacarídeo pneumocócico

Country Status (19)

Country Link
US (1) US6642017B2 (pt)
EP (2) EP1268844B1 (pt)
JP (1) JP4856345B2 (pt)
KR (3) KR20080081978A (pt)
CN (2) CN101586143A (pt)
AT (1) ATE437955T1 (pt)
AU (2) AU2001245795B2 (pt)
BR (1) BRPI0109293B8 (pt)
CA (1) CA2403001C (pt)
CY (1) CY1109418T1 (pt)
DE (1) DE60139384D1 (pt)
DK (1) DK1268844T3 (pt)
ES (1) ES2330919T3 (pt)
HK (1) HK1055448A1 (pt)
IL (3) IL151772A0 (pt)
MX (1) MXPA02009047A (pt)
NZ (1) NZ521343A (pt)
PT (1) PT1268844E (pt)
WO (1) WO2001068903A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1268844B1 (en) * 2000-03-16 2009-07-29 The Children's Hospital Of Philadelphia Modulating production of pneumococcal capsular polysaccharide
US7709001B2 (en) * 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
US7718791B2 (en) * 2005-04-08 2010-05-18 Wyeth Llc Separation of contaminants from Streptococcus pneumoniae polysaccharide by pH manipulation
US7491517B2 (en) * 2006-07-19 2009-02-17 Jeeri R Reddy Method of producing meningococcal meningitis vaccine for Neisseria meningitidis serotypes A,C,Y, and W-135
RU2460539C2 (ru) * 2006-10-10 2012-09-10 Вайет СПОСОБ ОЧИСТКИ ПОЛИСАХАРИДОВ Streptococcus pneumoniae 3 ТИПА (ВАРИАНТЫ)
WO2009059054A2 (en) * 2007-10-30 2009-05-07 The Trustees Of The University Of Pennsylvania Bacteria strains an d bacteriocin produced therefrom
DK2379734T3 (en) * 2008-12-18 2018-04-23 Wyeth Llc Method for Controlling the Molecular Weight of Polysaccharide of Streptococcus Pneumoniae Serotype 19A
PL2385981T3 (pl) * 2008-12-18 2020-01-31 Wyeth Llc Sposób kontroli masy cząsteczkowej polisacharydów streptococcus pneumoniae z zastosowaniem węgla
CN102093963B (zh) * 2010-11-26 2012-11-14 兰州生物制品研究所有限责任公司 富含磷壁酸的肺炎链球菌的培养方法
US9975801B2 (en) 2014-07-31 2018-05-22 Corning Incorporated High strength glass having improved mechanical characteristics
WO2015169774A1 (en) * 2014-05-07 2015-11-12 Glaxosmithkline Biologicals S.A. Purification of secreted polysaccharides from s. agalactiae
US11097974B2 (en) 2014-07-31 2021-08-24 Corning Incorporated Thermally strengthened consumer electronic glass and related systems and methods
US10611664B2 (en) 2014-07-31 2020-04-07 Corning Incorporated Thermally strengthened architectural glass and related systems and methods
WO2017123573A2 (en) 2016-01-12 2017-07-20 Corning Incorporated Thin thermally and chemically strengthened glass-based articles
US11795102B2 (en) 2016-01-26 2023-10-24 Corning Incorporated Non-contact coated glass and related coating system and method
WO2019040818A2 (en) 2017-08-24 2019-02-28 Corning Incorporated GLASSES HAVING ENHANCED TEMPERATURE CAPABILITIES
TWI785156B (zh) 2017-11-30 2022-12-01 美商康寧公司 具有高熱膨脹係數及對於熱回火之優先破裂行為的非離子交換玻璃
EP3744829A4 (en) * 2018-01-22 2021-10-27 The Research Foundation For Microbial Diseases Of Osaka University MEDIUM FOR GROWING PNEUMOCOCCAL SAMPLES
CN114514115B (zh) 2019-08-06 2023-09-01 康宁股份有限公司 具有用于阻止裂纹的埋入式应力尖峰的玻璃层压体及其制造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2510606A1 (fr) * 1981-07-30 1983-02-04 Berri Balzac Procede d'obtention de polyosides capsulaires, polyosides capsulaires ainsi obtenus et leur application a la preparation de vaccins
CA2116261A1 (en) * 1993-04-20 1994-10-21 David E. Briles Epitopic regions of pneumococcal surface protein a
EP0804582A1 (en) * 1994-05-16 1997-11-05 The Uab Research Foundation $i(STREPTOCOCCUS PNEUMONIAE) CAPSULAR POLYSACCHARIDE GENES AND FLANKING REGIONS
EP1268844B1 (en) * 2000-03-16 2009-07-29 The Children's Hospital Of Philadelphia Modulating production of pneumococcal capsular polysaccharide

Also Published As

Publication number Publication date
EP1268844A1 (en) 2003-01-02
ES2330919T3 (es) 2009-12-17
IL191962A0 (en) 2008-12-29
KR20080081978A (ko) 2008-09-10
AU4579501A (en) 2001-09-24
KR20080036656A (ko) 2008-04-28
DE60139384D1 (de) 2009-09-10
MXPA02009047A (es) 2005-04-19
US20030021811A1 (en) 2003-01-30
NZ521343A (en) 2005-03-24
CA2403001A1 (en) 2001-09-20
ATE437955T1 (de) 2009-08-15
IL151772A0 (en) 2003-04-10
CN101586143A (zh) 2009-11-25
PT1268844E (pt) 2009-11-03
IL151772A (en) 2009-12-24
CA2403001C (en) 2012-07-03
CN1429276A (zh) 2003-07-09
JP4856345B2 (ja) 2012-01-18
KR100942738B1 (ko) 2010-02-17
BRPI0109293B1 (pt) 2015-05-19
HK1055448A1 (en) 2004-01-09
EP1967591A2 (en) 2008-09-10
KR100914702B1 (ko) 2009-08-28
DK1268844T3 (da) 2009-11-16
JP2003531584A (ja) 2003-10-28
AU2001245795B2 (en) 2005-07-28
BRPI0109293B8 (pt) 2021-05-25
EP1967591A3 (en) 2008-12-03
KR20030040196A (ko) 2003-05-22
IL191962A (en) 2010-12-30
EP1268844A4 (en) 2006-03-29
WO2001068903A1 (en) 2001-09-20
US6642017B2 (en) 2003-11-04
CY1109418T1 (el) 2014-08-13
EP1268844B1 (en) 2009-07-29
CN100529054C (zh) 2009-08-19

Similar Documents

Publication Publication Date Title
BR0109293A (pt) Métodos para produzir polissacarìdeo capsular a partir de um pneumococo pela manutenção do pneumococo em um meio de crescimento, para minorar uma infecção pneumocócica em um animal, para produzir uma preparação imunogênica para a administração a um animal em risco de desenvolver uma infecção pneumocócica, para produzir polissacarìdeo pneumocócico e para avaliar se um composto de teste é útil para minorar uma infecção pneumocócica em um animal
ATE248863T1 (de) Cyclodextrinderivate und verfahren zu deren herstellung
NO20010805L (no) Immunogent <beta>-propionamidokoblet polysakkarid-proteinkonjugat anvendbart som vaksine, fremstilt ved anvendelse av et N-akryloylert polysakkarid
BR0212470A (pt) Métodos para produção de um ingrediente ativo de uma droga ou agente diagnóstico em cultura em suspensão de células mdck
NO20062081L (no) Fremgangsmate
ES546038A0 (es) Un metodo para preparar un conjugado inmunogeno
BRPI9912177B8 (pt) epítopos de célula auxiliar t artificiais como imunoestimuladores para imunógenos de peptídeo sintéticos, imunógenos de peptídeo e método para a produção dos mesmos
FI932626A (fi) Av en patogenisk aemne haerledande antigenisk polysackarid deriverad oligosackarid
DE69922703D1 (de) Ureido-thiobuttersäurederivate als ppar-agonisten
FR2734484B1 (fr) Composition vaccinale liquide et procede de fabrication
NO20043834L (no) Farmasoytisk sammensetning omfattende N-((1-N-butyl-4-piperidinyl)metyl-3,4-dihydro-2H-(1,3)-oksazino(3,2-A)indol-l0-karboksyamid eller salter og fremgangsmate derfor omfattende torr granulering
ES501242A0 (es) Un procedimiento para la preparacion de un polisacarido antigenico.
EA200400195A1 (ru) Способ репродукции вируса
BRPI0401947A (pt) Método para produzir um l-aminoácido, e, bactéria
NO169820C (no) Fremgangsmaate for fremstilling av en mastittvaksine
HUP9801917A2 (hu) Immunogén készítmény, eljárás annak előállítására és vakcinaként történő alkalmazására
DE69617956D1 (de) Zusammensetzungen, welche adp-ribosyltransferase-aktivität aufweisen und methoden für ihre herstellung und die verwendung derselben
CY1105783T1 (el) Διαγνωση του τυπου κολικου σε βρεφη
NO981407L (no) Protein fra Helicobacter pylori
Ormsbee et al. A comparison of some biologic characteristics of isolates of the Legionnaires' disease bacterium
DE69615537T2 (de) Helicobacter pylori antigen
ID28174A (id) Turunan 5-imino-13-deoksi antrasiklin, penggunaannya, dan proses pembuatannya
SE9901961D0 (sv) Fimbrial proteins
SU1421332A1 (ru) Устройство дл восстановлени слуха
ES2060396T3 (es) Compuesto intermedio utilizado para la preparacion de deferoxamina.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 19/05/2015, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 16/03/2001 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 16/03/2021

B15V Prolongation of time limit allowed